DK0804254T3 - Varmebehandling af blodplasmaproteiner - Google Patents

Varmebehandling af blodplasmaproteiner

Info

Publication number
DK0804254T3
DK0804254T3 DK95940359T DK95940359T DK0804254T3 DK 0804254 T3 DK0804254 T3 DK 0804254T3 DK 95940359 T DK95940359 T DK 95940359T DK 95940359 T DK95940359 T DK 95940359T DK 0804254 T3 DK0804254 T3 DK 0804254T3
Authority
DK
Denmark
Prior art keywords
pct
heat treatment
sec
less
date
Prior art date
Application number
DK95940359T
Other languages
English (en)
Inventor
Ronald Vance Mcintosh
John Charles Hardy
Original Assignee
Common Services Agency
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Common Services Agency filed Critical Common Services Agency
Application granted granted Critical
Publication of DK0804254T3 publication Critical patent/DK0804254T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1025—Acyltransferases (2.3)
    • C12N9/104—Aminoacyltransferases (2.3.2)
    • C12N9/1044—Protein-glutamine gamma-glutamyltransferase (2.3.2.13), i.e. transglutaminase or factor XIII
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/02—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using physical processes
    • A61L2/04—Heat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10—Polypeptides; Proteins
    • A61L24/106—Fibrin; Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/75—Fibrinogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2103/00—Materials or objects being the target of disinfection or sterilisation
    • A61L2103/05—Living organisms or biological materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Wood Science & Technology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Materials For Medical Uses (AREA)
DK95940359T 1994-12-08 1995-12-08 Varmebehandling af blodplasmaproteiner DK0804254T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9424732.7A GB9424732D0 (en) 1994-12-08 1994-12-08 Heat treated blood plasma proteins
PCT/GB1995/002902 WO1996017631A1 (en) 1994-12-08 1995-12-08 Heat treated blood plasma proteins

Publications (1)

Publication Number Publication Date
DK0804254T3 true DK0804254T3 (da) 2003-06-30

Family

ID=10765577

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95940359T DK0804254T3 (da) 1994-12-08 1995-12-08 Varmebehandling af blodplasmaproteiner

Country Status (10)

Country Link
US (1) US5831027A (da)
EP (1) EP0804254B1 (da)
JP (2) JP4181214B2 (da)
AT (1) ATE233576T1 (da)
CA (1) CA2206670C (da)
DE (1) DE69529845T2 (da)
DK (1) DK0804254T3 (da)
ES (1) ES2193206T3 (da)
GB (1) GB9424732D0 (da)
WO (1) WO1996017631A1 (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5837519A (en) * 1996-11-21 1998-11-17 Bayer Corporation Dry-heat viral inactivation under controlled moisture conditions
US6503527B1 (en) 1997-11-17 2003-01-07 Haemacure Corporation Fibrin sealants or adhesives comprising a hyaluronic acid derivative material
ES2156731B1 (es) * 1999-05-31 2002-02-16 Grifols Grupo Sa Utilizacion del acido tranexamico para la preparacion de una composicion de fibrinogeno humano.
JP2001270900A (ja) * 2000-03-23 2001-10-02 Nihon Pharmaceutical Co Ltd フィブリノゲンのウイルス不活化法
GB0216001D0 (en) 2002-07-10 2002-08-21 Nat Blood Authority Process and composition
FR2857267B1 (fr) * 2003-07-09 2006-03-10 Lab Francais Du Fractionnement Formulation stabilisante et solubilisante pour les proteines cryoprecipitables.
FR2887883B1 (fr) 2005-06-29 2007-08-31 Lab Francais Du Fractionnement Procede de separation des proteines fibrinogene, facteur xiii et colle biologique d'une fraction plasmatique solubilisee et de preparation de concentres lyophilises desdites proteines
FR2894830B1 (fr) * 2005-12-19 2008-04-04 Lab Francais Du Fractionnement Procede d'inactivation virale par chauffage a sec selon la temperature de transition vitreuse
US9110008B2 (en) * 2010-07-26 2015-08-18 Los Gatos Research Method for isotopic analysis of water in bodily fluids
US20140287044A1 (en) * 2011-03-04 2014-09-25 Rare Antibody Antigen Supply, Inc. Fibrin sealant (fibringluraas) consisting of a kit of lyophilized or frozen high concentrate fribinogen
EP3694322B1 (en) 2017-10-09 2024-07-03 Terumo BCT Biotechnologies, LLC Lyophilization container and method of using same
US11754478B2 (en) 2018-08-16 2023-09-12 Abb Schweiz Ag Rapid equilibrator for water isotope analysis
US11604026B2 (en) 2019-03-14 2023-03-14 Terumo Bct Biotechnologies, Llc Lyophilization loading tray assembly and system
CN118344463B (zh) * 2024-05-15 2024-12-13 广东丹霞生物制药有限公司 一种人纤维蛋白原的制备方法及产品

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4456590B2 (en) * 1981-11-02 1989-05-30 Heat treatment of lyphilized blood clotting factor viii concentrate
US4650858A (en) * 1983-03-21 1987-03-17 Nordisk Gentofte A/S Concentrate of the antihemophilic factor VIII and a process for producing it
AT390001B (de) * 1984-09-28 1990-03-12 Immuno Ag Verfahren zur inaktivierung von vermehrungsfaehigen filtrierbaren krankheitserregern
ATE52922T1 (de) * 1985-08-05 1990-06-15 Immuno Ag Verfahren zur herstellung von praeparationen auf basis von blutgerinnungsfaktoren.
AU6487286A (en) * 1985-11-08 1987-05-14 Baxter Travenol Laboratories Inc. Antihemophilic factor by cold precipitation
AU2251288A (en) * 1987-05-15 1988-12-06 Alan I. Rubinstein Sequential improved method for treatment of human blood- clotting factor products
US5099002A (en) * 1987-05-15 1992-03-24 University Of Southern California Sequential improved method for treatment of human blood-clotting factor products
DK708488D0 (da) * 1988-12-20 1988-12-20 Nordisk Gentofte Faktor i praeparat
USH1509H (en) * 1989-06-09 1995-12-05 Eran; Harutyun Heparin enhanced process for separating antihemophilic factor (Factor VIII) and fibronectin from cryoprecipitate
AT402788B (de) * 1993-08-03 1997-08-25 Immuno Ag Virussichere blutgerinnungsfaktor xiii-präparation

Also Published As

Publication number Publication date
DE69529845T2 (de) 2003-12-11
ES2193206T3 (es) 2003-11-01
AU4183296A (en) 1996-06-26
JPH10510257A (ja) 1998-10-06
EP0804254A1 (en) 1997-11-05
ATE233576T1 (de) 2003-03-15
US5831027A (en) 1998-11-03
DE69529845D1 (de) 2003-04-10
WO1996017631A1 (en) 1996-06-13
AU692018B2 (en) 1998-05-28
JP2008044963A (ja) 2008-02-28
EP0804254B1 (en) 2003-03-05
CA2206670C (en) 2008-02-19
JP4181214B2 (ja) 2008-11-12
CA2206670A1 (en) 1996-06-13
GB9424732D0 (en) 1995-02-08

Similar Documents

Publication Publication Date Title
US5395923A (en) Process for the obtention of a biological adhesive made of concentrated coagulation factors by "salting-out"
CA1199275A (en) Method of achieving hemostasis
DK0804254T3 (da) Varmebehandling af blodplasmaproteiner
FI77985C (fi) Foerfarande foer framstaellning av en fibrinogenprodukt.
US4470968A (en) Pasteurized therapeutically active blood coagulation factor concentrates
DE69011136T3 (de) Verfahren zur Herstellung einer Protein enthaltenden Zusammensetzung.
US5639730A (en) Method of producing a virus-safe biological preparation
DE69231791T2 (de) Verbesserter Gewebekleber, zubereitet aus Kryopräzipitat
CA2128795C (en) A virus-safe blood coagulation factor xiii preparation
DK167900B1 (da) Middel til behandling og forebyggelse af haemostatiske forstyrrelser indeholdende vaevsprotein pp4
NO138145B (no) Fremgangsmaate for fremstilling av et enzympreparat
CA1297011C (en) Method of producing a factor viii (ahf) containing fraction
AU658238B2 (en) A process for the production of a virus-free concentrate of thrombin
Mongar et al. Potentiation of the action of histamine by semicarbazide
IE70455B1 (en) Pasteurized glue for joining human or animal tissues
US4386161A (en) Process for the preparation of incoagulable blood by means of proteolytic enzymes and protein concentrate prepared therefrom
FI96918B (fi) Koostumus veriplasman stabiloimiseksi pastöroinnin aikana
CA2228031A1 (en) Doubly virus-inactivated human blood plasma, blood plasma derivatives produced therefrom and method for their production
NO175622B (da)
Banerjee et al. Isolation and purification of a coagulant from snake venom of the species Bothrops jararaca and the study of its properties
FI109766B (fi) Menetelmä eskaraasia sisältävän proteolyyttisen seoksen valmistamiseksi
AT402151B (de) Verfahren zur herstellung eines virussicheren biologischen präparates
DK175644B1 (da) Fremgangsmåde til stabilisering af biologiske og farmaceutiske midler under inaktivering af virale og bakterielle kontaminanter
Arturson et al. Use of human fibrin glue in burn wound surgery
Breddin Perspectives of the Clinical use of Hirudin